[1]
|
K. A. Ault, “Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract,” Infectious Diseases in Obstetrics and Gynecology, Vol. 2006, No.1, January 2006, pp. 1-5.
|
[2]
|
M. Schiffman and D. Solomon, “Findings to Date from the ASCUS-LSIL Triage Study (ALTS),” Archives of Pathology and Laboratory Medicine, Vol. 127, No. 8, August 2003, pp. 946-949.
|
[3]
|
The ASCUS-LSIL Triage Study (ALTS) Group, “A Randomized Trial on the Management of Low-Grade Squamous Intraepithelial Lesions Cytology Interpretations,” American Journal of Obstetrics and Gynecology, Vol. 188, No. 6, June 2003, pp. 1393-1400.
|
[4]
|
M. Kyrgiou, G. Koliopoulos, P. Martin-Hirsch, M. Arbyn, W. Prendiville and E. Paraskeviadis, “Obstetric Outcomes after Conservative Treatment for Intraepithelial or Early Invasive Cervical Lesions: Systematic Review and Metaanalysis,” The Lancet, Vol. 367, No. 9509, February 2006, pp. 489-498.
doi:10.1016/S0140-6736(06)68181-6
|
[5]
|
C. Penna, M. G. Fallani, R. Gordigiani, L. Sonni, G. L. Taddei and M. Marchionni, “Intralesional Beta-Interferon Treatment of Cervical Intraepithelial Neoplasia Associated with Human Papillomavirus Infection,” Tumori, Vol. 80, No. 2, February 1994, pp. 146-150.
|
[6]
|
M. Katesmark, S. Coulter-Smith, K. Reynolds and F. Lawton, “A Pilot Study of the Efficacy and Tolerability of Intralesional Recombinant Human Beta Interferons in Cervical Intraepithelial Neoplasia,” Annals Academy of Medicine Singapore, Vol. 28, No. 6, November 1999, pp. 775-777.
|
[7]
|
R. Zarcone, P. Bellini, G. Cardone and A Cardone, “Treatment of Cervix Condylomata with Alpha-IFN Leucocytar,” Clinical and Experimental Obstetrics and Gynecology, Vol. 22, No. 4, March 1995, pp. 326-329.
|